陈耀明, 蔡纯一, 龚康孙. N-(4-乙氧羰基-4-取代丁酰基)-N-取代甘氨酸的合成J. 药学学报, 1989, 24(12): 887-894.
引用本文: 陈耀明, 蔡纯一, 龚康孙. N-(4-乙氧羰基-4-取代丁酰基)-N-取代甘氨酸的合成J. 药学学报, 1989, 24(12): 887-894.
YM Chen, CY Cai , KS Gong, . SYNTHESIS OF N-(4-CARBETHOXY-4-SUBSTITUTED BUTYRYL)-N-SUBSTITUTED GLYClNESJ. Acta Pharmaceutica Sinica, 1989, 24(12): 887-894.
Citation: YM Chen, CY Cai , KS Gong, . SYNTHESIS OF N-(4-CARBETHOXY-4-SUBSTITUTED BUTYRYL)-N-SUBSTITUTED GLYClNESJ. Acta Pharmaceutica Sinica, 1989, 24(12): 887-894.

N-(4-乙氧羰基-4-取代丁酰基)-N-取代甘氨酸的合成

SYNTHESIS OF N-(4-CARBETHOXY-4-SUBSTITUTED BUTYRYL)-N-SUBSTITUTED GLYClNES

  • 摘要: 本文报道9个估计具有血管紧张素转化酶抑制活性的N-(4-乙氧羰基-4-取代丁酰基)-N-取代甘氨酸及其相应叔丁酯的合成和鉴定。药理初试结果,化合物Ⅶ7和Ⅶ9显示明显降压活性。

     

    Abstract: This paper reports the synthesis of nine N-(4-carbethoxy-4-substituted butyryl)-N-substituted glycines and their corresponding t-butyl esters. The former were expected to have inhibitory activity of angiotensin-converting enzyme. All of the compounds mentioned above were unreported in the literature. In preliminary test in rats, compounds Ⅶ7 and Ⅶ9 showed marked hypotensive activity.

     

/

返回文章
返回